Proposal to list obstetrics and gynaecology products supplied by Pro-Med Technologies Limited

Hospital devices Consultation Closed

PHARMAC is seeking feedback on a proposal to list a range of obstetrics and gynaecology products in Part III of Section H of the Pharmaceutical Schedule.

What we’re proposing

PHARMAC is seeking feedback on a proposal to list a range of obstetrics and gynaecology products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019 through a provisional agreement with Pro-Med Technologies Limited (“ProMed”).

Consultation closes at 4pm on Thursday, 6 June 2019 and feedback can be emailed to

What would the effect be?

For DHBs

From 1 July 2019, ProMed’s range of obstetrics and gynaecology products would be listed under the proposed national agreement (“Agreement”) that all DHBs may purchase under, subject to consultation and approval by PHARMAC’s Board or delegate.

The Agreement would not be for sole supply, with DHBs continuing to be able to purchase other suppliers’ brands of obstetrics and gynaecology products.

The Agreement would supersede any existing DHB contract with the supplier for the devices listed in the Schedule 1 of the Agreement.  Any device listed in a PHARMAC Agreement and purchased by a DHB would be at the price, terms and conditions stated in the Agreement, effective from the date of listing on the Pharmaceutical Schedule.

PHARMAC estimates that the ProMed Agreement will result in cost savings for DHBs based on current usage of the proposed products.

Who we think will be interested

  • DHB Staff
    • Theatre staff
    • Obstetricians, gynaecologists and surgeons
    • Surgical, gynaecology and general ward staff
    • Delivery suite staff
    • Midwives
    • Procurement Officers
  • Suppliers and Wholesalers

About obstetric and gynaecology products

This category includes all equipment and consumables used in the obstetric and gynaecology specialities. Products used in delivery suites and by midwives on the wards are included. Gynaecology is the specialty that treats conditions related to female reproductive organs. A small number of devices related to fertility and sterility may be listed as some limited assisted reproduction services are provided by a small number of DHB Hospitals. However most funded services are provided by private clinics are therefore out of scope for PHARMAC. 

Why we’re proposing this

In October 2018 PHARMAC issued a Request for Proposals (“RFP”) for obstetric and gynaecological products.

The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

PHARMAC has been working with suppliers in order to seek provisional agreements and this is the third proposal to arise from that process. We intend to consult on proposed agreements with other suppliers over the next few months.

Details about our proposal

PHARMAC has entered into a provisional Agreement with ProMed for the supply of 38 obstetrics and gynaecology products in the following ranges:

  • Amaryll Kombikit
  • Ardo
  • Breast Shell
  • Calypso Pro
  • Carum
  • Clinic pumpset
  • Clinistore
  • Clinicare pumpset
  • Easy Clean Bags
  • Ebb
  • Kiwi Omnicup
  • Koala
  • Onemum Pumpset
  • Traxi
  • Tulip Nipple shield

Pricing has been made available to appropriate DHB personnel.

To provide feedback

Send us an email: by 4pm, Thursday 6 June 2019.

All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.

Feedback we receive is subject to the Official Information Act 1982 (OIA) and we will consider any request to have information withheld in accordance with our obligations under the OIA. Anyone providing feedback, whether on their own account or on behalf of an organisation, and whether in a personal or professional capacity, should be aware that the content of their feedback and their identity may need to be disclosed in response to an OIA request.

We are not able to treat any part of your feedback as confidential unless you specifically request that we do, and then only to the extent permissible under the OIA and other relevant laws and requirements. If you would like us to withhold any commercially sensitive, confidential proprietary, or personal information included in your submission, please clearly state this in your submission and identify the relevant sections of your submission that you would like it withheld. PHARMAC will give due consideration to any such request.